CSURGSU

The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Centenial Surgical latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Inventory

Balance sheet of Centenial Surgical is moderately strong, But short term working capital might become an issue for this company.

Yes, profit is increasing. The profit of Centenial Surgical is ₹1.13 Crs for Mar 2024, ₹0.89 Crs for Mar 2023 and ₹0.63 Crs for Mar 2022

The debt of Centenial Surgical is decreasing. Latest debt of Centenial Surgical is -₹1.15 Crs as of Sep-24. This is less than Mar-24 when it was ₹13.09 Crs.

Centenial Surgical is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE. Latest PE of Centenial Surgical is 0.0, while 3 year average PE is 28.38. Also latest EV/EBITDA of Centenial Surgical is 8.04 while 3yr average is 5.72.

Centenial Surgical has given better returns compared to its competitors. Centenial Surgical has grown at ~29.76% over the last 5yrs while peers have grown at a median rate of 21.0%

Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Centenial Surgical is 46.89% and last quarter promoter holding is 46.89%.

There is Insufficient data to gauge this.